Savings in medical expenditures associated with reductions in body mass index among US Adults with Obesity, by Diabetes Status
Open accessAbstract
BACKGROUND: The prevalence of obesity has more than doubled in the USA in the past 30 years. Obesity is a significant risk factor for diabetes, cardiovascular disease, and other clinically significant co-morbidities. This paper estimates the medical care cost savings that can be achieved from a given amount of weight loss by people with different starting values of body mass index (BMI), for those with and without diabetes. This information is an important input into analyses of the cost effectiveness of obesity treatments and prevention programs. METHODS: Two-part models of instrumental variables were estimated using data from the Medical Expenditure Panel Survey (MEPS) for 2000-2010. Models were estimated for all adults as well as separately for those with and without diabetes. We calculated the causal impact of changes in BMI on medical care expenditures, cost savings for specific changes in BMI (5, 10, 15, and 20 %) from starting BMI levels ranging from 30 to 45 kg/m(2), as well as the total excess medical care expenditures caused by obesity. RESULTS: In the USA, adult obesity raised annual medical care costs by $US3,508 per obese individual, for a nationwide total of $US315.8 billion (year 2010 values). However, the relationship of medical care costs over BMI is J-shaped; costs rise exponentially in the range of class 2 and 3 obesity (BMI ≥35). The heavier the obese individual, the greater the reduction in medical care costs associated with a given percent reduction in BMI. Medical care expenditures are higher, and rise more with BMI, among individuals with diabetes than among those without diabetes. CONCLUSIONS: The savings from a given percent reduction in BMI are greater the heavier the obese individual, and are greater for those with diabetes than for those without diabetes. The results provide health insurers, employers, government agencies, and health economists with accurate estimates of the change in medical care expenditures resulting from weight loss, which is important information for calculating the cost effectiveness of interventions to prevent and treat obesity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reducing cardiovascular risk may reduce healthcare expenditures, which may unburden both patients and the U.S. health care system at large.
“Moreover, reducing cardiovascular risk may reduce healthcare expenditures, which may unburden both patients and the U.S. health care system at large [49], [50], [51].”
From Income disparity and utilization of cardiovascular preventive care services among U.S. adults (2021) · cites this paper as [49]
The Background identifies obesity as a cardiovascular-disease risk factor, and the Conclusions estimate medical-expenditure savings from BMI reductions for individuals and society. The paper does not establish that reducing cardiovascular risk itself produces those savings or that patients’ own healthcare expenses fall. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 48 · Cited by 184
Research works printed but not linked: 33
- [1]Burkhauser RV Cawley J Schmeiser MD The timing of the rise in U.S. obesity varies with measure of fatness Econ Hum Biol 2009 7 3 307 318 10.1016/j.ehb.2009.07.006 19729352 · DOI
- [4]Dixon JB The effect of obesity on health outcomes Mol Cell Endocrinol 2010 316 2 104 108 10.1016/j.mce.2009.07.008 19628019 · DOI
- [5]Hu FB Obesity epidemiology 2008 New York Oxford University Press
- [6]Winter Y Sankowski R Back T Genetic determinants of obesity and related vascular diseases Vitam Horm 2013 91 29 48 10.1016/B978-0-12-407766-9.00002-X 23374711 · DOI
- [7]Trayhurn P Beattie JH Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ Proc Nutr Soc 2001 60 3 329 339 10.1079/PNS200194 11681807 · DOI
- [9]Malnick SDH Knobler H The medical complications of obesity QJM 2006 99 9 565 579 10.1093/qjmed/hcl085 16916862 · DOI · Paper page
- [10]McLaren L. Socioeconomic Status and Obesity. In: Cawley JHJ, editor. The Oxford handbook of the social science of obesity. New York: Oxford University Press; 2011. pp. xvi, 894.
- [11]Cawley J, Burkhauser R. Beyond BMI: the value of more accurate measures of fatness and obesity in social science research. NBER Working Paper No. 12291. National Bureau of Economic Research. June 2006. Available from: http://www.nber.org/papers/w12291.pdf. Accessed 14 Oct 2014. 18166236
- [12]Bound J Brown C Mathiowetz N Heckman JJ Leamer E Measurement error in survey data Handbook of econometrics 2002 New York Springer 3705 3843
- [13]Finkelstein EAE Trogdon JGJ Cohen JJW Dietz W Annual medical spending attributable to obesity: payer-and service-specific estimates Health Aff (Millwood) 2009 28 5 w822 w831 10.1377/hlthaff.28.5.w822 19635784 · DOI
- [14]Trasande L Liu Y Fryer G Weitzman M Effects of childhood obesity on hospital care and costs, 1999–2005 Health Aff (Millwood) 2009 28 4 w751 w760 10.1377/hlthaff.28.4.w751 19589800 · DOI
- [15]Thorpe KE, Florence CS, Howard DH, Joski P. The impact of obesity on rising medical spending. Health Aff (Millwood). 2004;Suppl Web W4–480–6. 15496437
- [16]Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who’s paying? Health Aff (Millwood). 2003;Suppl Web:W3–219–26. 14527256
- [17]Cawley J Meyerhoefer C The medical care costs of obesity: an instrumental variables approach J Health Econ 2012 31 1 219 230 10.1016/j.jhealeco.2011.10.003 22094013 · DOI
- [19]Jones A. Health econometrics. In: Culyer AJ, Newhouse JP, editors. Handbook of health economics, chap. 6, vol. 1A; 2000. pp. 265–336.
- [20]Manning WG Mullahy J Estimating log models: to transform or not to transform? J Health Econ 2001 20 4 461 494 10.1016/S0167-6296(01)00086-8 11469231 · DOI
- [24]Cawley J The impact of obesity on wages J Hum Resour 2004 39 2 451 474 10.2307/3559022 · DOI
- [25]Kline B Tobias JL The wages of BMI: Bayesian analysis of a skewed treatment-response model with nonparametric endogeneity J Appl Econ 2008 23 6 767 793 10.1002/jae.1028 · DOI
- [26]Smith DG, Sterne JAC, Fraser A, Tynelius P, Lawlor DA, Rasmussen F. The association between BMI and mortality using offspring BMI as an indicator of own BMI: large intergenerational mortality study. BMJ. 2009;339:b5043. PMC2797052 20028778
- [27]Farooqi IS O’Rahilly S Genetic factors in human obesity Obes Rev 2007 8 Suppl 1 37 40 10.1111/j.1467-789X.2007.00315.x 17316299 · DOI
- [28]Pietilainen KH Haslam DW Sharma AM Le Roux CW Genetics and epigenetics: myths or facts? Controversies in obesity 2014 London Springer
- [29]Stock J Wright J Yogo M A survey of weak instruments and weak identification in generalized method of moments J Bus Econ Stat 2002 20 4 518 529 10.1198/073500102288618658 · DOI
- [30]Grilo CM Pogue-Geile MF The nature of environmental influences on weight and obesity: a behavior genetic analysis Psychol Bull 1991 110 3 520 537 10.1037/0033-2909.110.3.520 1758921 · DOI
- [31]Wardle J Carnell S Haworth CM Plomin R Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment Am J Clin Nutr 2008 87 2 398 404 18258631
- [32]Davis K. Sample design of the 2011 medical expenditure panel survey insurance component. Methodology Report #27. Rockville: Agency for Healthcare Research and Quality; 2013. Available from http://www.meps.ahrq.gov/mepsweb/datafiles/publications/mr27/mr27.pdf. 38416859
- [33]Black D Berger M Scott F Bounding parameter estimates with nonclassical measurement error J Am Stat Assoc 2000 95 451 739 748 10.1080/01621459.2000.10474262 · DOI
- [34]Frazis H Loewenstein MA Estimating linear regressions with mismeasured, possibly endogenous, binary explanatory variables J Econ 2003 117 1 151 178 10.1016/S0304-4076(03)00121-0 · DOI
- [36]Krewski D Rao JNK Inference from stratified samples: properties of the linearization, jackknife and balanced repeated replication methods Ann Stat 1981 9 5 1010 1019 10.1214/aos/1176345580 · DOI
- [37]Flegal KM Kit BK Orpana H Graubard BI Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis JAMA 2013 309 1 71 82 10.1001/jama.2012.113905 23280227 PMC4855514 · DOI · Paper page
- [38]Mehta NK Chang VW Mortality attributable to obesity among middle-aged adults in the United States Demography 2009 46 4 851 872 10.1353/dem.0.0077 20084832 PMC2831354 · DOI
- [42]Fontaine KR, Bartlett SJ. Access and use of medical care among obese persons. Obes Res. 2000;8(5):403–6. 10968733
- [43]Small D, Rosenbaum PR. War and wages: the strength of instrumental variables and their sensitivity to unobserved biases. J Am Stat Assoc. 2008;103(483):924–33.
- [44]Burkhauser RV, Cawley J. Beyond BMI: the value of more accurate measures of fatness and obesity in social science research. J Health Econ. 2008;27(2):519–29. 18166236
- Authors
- Cawley, J., Meyerhoefer, C., Biener, A., Hammer, M., & Wintfeld, N.
- Affiliations
- Cornell University (US)
- Lehigh University (US)
- Corresponding author
- Cawley, John
- Venue
- PharmacoEconomics
- Published
- 2014-11-09
- Volume
- 33
- Issue
- 7
- Pages
- 707-722
- ISSN
- 1170-7690 (ISSN-L)
- 1179-2027
- PMC
- PMC4486410
- OpenAlex
- W2135610518
- Cited by
- 184
- References
- 48
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 15 · 2023: 18 · 2022: 11 · 2021: 15 · 2020: 16 · 2019: 18 · 2018: 17 · 2017: 22 · 2016: 24 · 2015: 14 · 2013: 1
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- PharmacoEconomics (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Health Professions › Pharmacy › Obesity and Health Practices
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- obesity, body mass index, weight loss, health care costs, diabetes mellitus, cost reduction, Medical Expenditure Panel Survey
- MeSH terms
- Adult, Delivery of Health Care, Diabetes Mellitus, Type 2, Health Expenditures, Humans, Obesity, United States, Body Mass Index, Cost Savings, Models, Econometric, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review